Skip to Content

Hershey Earnings: Margin Gains Not Enough to Placate the Market, Rendering Shares a Bit Undervalued

Consumer Defensive Sector artwork

While our $196 fair value estimate shouldn’t see much change, the market continued to sour on wide-moat Hershey HSY despite fair third-quarter marks: 10.7% organic sales growth, 240 basis points of adjusted gross margin expansion to 44.9%, and a 230-basis-point bump in adjusted operating margin to 24.9%. In this context, Hershey’s stock price is down around 17% since January but has slid around 30% from its peak in early May.

We attribute the weakness to a host of concerns, ranging from potential volume degradation as a byproduct of increased usage of weight-loss drugs to whether penny-pinching consumers could leave confectionery fare on the shelf in favor of more essential, daily products. Despite these looming headwinds, we surmise Hershey is playing from a position of strength, given its dominant standing (controlling around 45% of the U.S. chocolate space) combined with the robust resources it maintains to ensure its lineup continues to evolve with consumer trends.

In this context, we’re encouraged that it is firm in its commitment to funnel resources toward its brands, with advertising spending up around 20% in the period; we think Hershey will expend a high-single-digit percentage of sales (nearly $1 billion) toward research, development, and marketing annually over the next 10 years. And even though management has been forthright that its innovation pipeline was a bit scant this year, this coincided with stepped-up spending to build out its capabilities and capacity (with capital expenditures set to approximate 7%-8% of sales, outpacing the less than 5% average that has historically characterized the business), which we see as prudent. And with these investments in the rearview, we think Hershey intends to flavor its mix over the coming quarters.

When taken together, the recent downdraft is creating an interesting opportunity for investors looking to indulge, in our view, with shares trading below our intrinsic valuation for the first time in about four years.

The author or authors do not own shares in any securities mentioned in this article. Find out about Morningstar’s editorial policies.

More in Stocks

About the Author

Erin Lash

Sector Director
More from Author

Erin Lash, CFA, is director of consumer sector equity research for Morningstar Research Services LLC, a wholly owned subsidiary of Morningstar, Inc. In addition to leading the sector team, Lash covers packaged food and household and personal care companies.

Before joining Morningstar in 2006, she spent four years as an investment analyst covering retail, transportation, and technology firms for State Farm Insurance.

Lash holds a bachelor’s degree in finance from Bradley University and a master’s degree in business administration, with concentrations in accounting and finance, from the University of Chicago Booth School of Business. She also holds the Chartered Financial Analyst® designation. She ranked second in the food and tobacco industry in The Wall Street Journal’s annual “Best on the Street” analysts survey in 2013, the last year the survey was conducted.

Sponsor Center